COMPANY
Introduction
MEDI-IoT (메디아이오티) is a BT (Bio Technology) convergence company that provides digital prevention/management/treatment solutions in the fields of eye diseases and geriatric diseases. Currently, we offer the eye disease treatment device MEDI-EYE (메디아이) and DTx platform called AgingLOC (에이징락), which diagnoses and provides tailored treatment programs for geriatric diseases. MEDI-IoT provides optimal solutions that meet the needs of customers in the fields of eye diseases and geriatric diseases and has a differentiated approach that sets new standards for treatment. We strive to become a pioneer in the digital healthcare field through continuous research and innovation, and we are committed to improving people's quality of daily life.
History
Participation and Innovation Award at Hong Kong InnoEx 2024
Obtained MEDI-EYE KC Certification
Medical Device Clinical Trial Application to MFDS
Hongneung Innopolis H-Bridge Project
TIPS Linked Support Overseas Marketing Project
Gyeongnam Technopark Electronic Medicine, Digital Therapeutics Technology Commercialization Base
Selected for TIPS (Linked Support Overseas Marketing)
Participated in the China Changchun Northeast Asia Big Health Forum
Secured Statistical Significance in Preclinical Trials (in vivo, in vitro; Dry Eye Syndrome, Dry Macular Degeneration, Macular Edema)
Participated in the Finland Radical Healthcare Festival
Selected for TIPS (Linked Support Startup Commercialization)
Secured Investment from ScaleUp Partners
Participated in CES 2023
Selected for TIPS (Startup Incubating Support Project)
Secured Investment from Hana Securities, Company X
Secured Investment from Daewoong Pharmaceutical
Company Name Changed (TechOnHeal -> MediIOT)
Obtained Class 1 Medical Manufacturing License
Established an Affiliated Research Institute
Company Founded